SCHEMBL27561963

SCHEMBL27561963

NC(=O)OS(=O)(=O)NC(c1ccccc1)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2D6 P10635 1/20 0.42
PKM P14618 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
KMT2A Q03164 2/20 0.41
MEN1 O00255 1/20 0.41
GAA P10253 1/20 0.41
CA1 P00915 3/20 0.40
CA2 P00918 3/20 0.40
CA12 O43570 2/20 0.40
CA9 Q16790 2/20 0.40
ACLY P53396 1/20 0.39
TSHR P16473 1/20 0.39
ALDH1A1 P00352 1/20 0.39
CTSD P07339 1/20 0.38
SRC P12931 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27561882 0.74 LMNA (0.47) LMNAKMT2AMEN1GAACA1
SCHEMBL4557719 0.72 CYP2C19 (0.43) LMNACYP1A2CYP2D6PKMSMN1; SMN2
SCHEMBL27617107 0.71 CA1 (0.46) LMNACA1CA2CA12CA9
SCHEMBL27582572 0.71 CA1 (0.46) KMT2ACA1CA2CA12CA9
Acetic Acid SCHEMBL9574999 0.69 ALDH1A1 (0.45) LMNACYP1A2CYP2D6KMT2AGAA
SCHEMBL6639307 0.69 LMNA (0.42) LMNACYP2D6GAACA1CA2
SCHEMBL27995434 0.69 CTSD (0.50) CYP1A2CYP2D6PKMSMN1; SMN2NPSR1
SCHEMBL28352597 0.68 LMNA (0.53) LMNACYP1A2CYP2D6PKMSMN1; SMN2
SCHEMBL4224462 0.68 CYP2C19 (0.55) KMT2ACA1CA2CA12CA9
SCHEMBL7574319 0.67 MTOR (0.43) LMNANPSR1KMT2AGAACA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1404829-A Double inhibitor synthesized by wax ester and cholesterol ester for inbibiting generation of sebum WARNER LAMBERT CO (US) 2003-03-26 CN claimed
CN-1370526-A Treating method of nuclear factor-KB mediated diseases and dysfuction WANER LONGBER CO (US) 2002-09-25 CN claimed
CN-1404829-A Double inhibitor synthesized by wax ester and cholesterol ester for inbibiting generation of sebum WARNER LAMBERT CO (US) 2003-03-26 CN disclosed
CN-1370526-A Treating method of nuclear factor-KB mediated diseases and dysfuction WANER LONGBER CO (US) 2002-09-25 CN disclosed